Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07108517Not ApplicableRecruiting

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

Role: collaborator

NCT04140630Unknown

Exposure to E-cigarette Aerosols in Real-life Conditions

Role: collaborator

NCT03151421Not ApplicableCompleted

Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home

Role: collaborator

NCT03102684Not ApplicableUnknown

Impact of Secondhand Exposure to E-cigarettes Aerosols on the Respiratory System

Role: collaborator

All 4 trials loaded